Vanguard Group Inc Alkermes Plc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Vanguard Group Inc holds 20,161,180 shares of ALKS stock, worth $487 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,161,180
Previous 20,955,454
3.79%
Holding current value
$487 Million
Previous $581 Million
6.11%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$705 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$360 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$218 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$201 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY6.05MShares$146 Million2.63% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.97B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...